Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

7.390
+0.0200.27%
Volume:59.81M
Turnover:442.28M
Market Cap:138.64B
PE:35.27
High:7.480
Open:7.270
Low:7.240
Close:7.370
52wk High:9.120
52wk Low:2.634
Shares:18.76B
HK Float Shares:18.76B
Volume Ratio:1.47
T/O Rate:0.32%
Dividend:0.09
Dividend Rate:1.23%
EPS(LYR):0.210
ROE:15.40%
ROA:5.07%
PB:3.79
PE(LYR):35.27
PS:4.14

Loading ...

Sino Biopharmaceutical Stock Advances 1.1% in Hong Kong

Dow Jones
·
Sep 08

China Merchants International: Chinese Pharmaceutical Stocks Expected to Continue Rising on Innovation Drug Overseas Expansion and Domestic Policy Optimization, Recommends Buying 3SBIO (01530) and Others

Stock News
·
Sep 08

Sino Biopharmaceutical Stock Sheds 2.8% in Hong Kong

Dow Jones
·
Sep 04

Sino Biopharmaceutical Stock Slides 1.4% in Hong Kong

Dow Jones
·
Sep 02

Sino Biopharmaceutical Stock Rallies 6.2% in Hong Kong

Dow Jones
·
Sep 01

Sino Biopharmaceutical Limited Secures Regulatory Approval for Hernexeos® Tablets in China for HER2-Mutant NSCLC Treatment

Reuters
·
Aug 29

Sino Biopharmaceutical - Zongertinib Tablets Approved for Marketing by Nmpa

THOMSON REUTERS
·
Aug 29

Stock Track | Sino Biopharm Soars 5.07% on Massive Insider Purchase by Founder

Stock Track
·
Aug 29

Sino Biopharmaceutical Stock Slides 2.1% in Hong Kong

Dow Jones
·
Aug 28

SINO BIOPHARM (01177) to Present Research Results on "TQC3721 (PDE3/4 Inhibitor)", "TQC2731 (TSLP Monoclonal Antibody)", and "TQC3403 (Umeclidinium Bromide Vilanterol Dry Powder Inhaler)" at ERS 2025

Stock News
·
Aug 25

Sino Biopharmaceutical Stock Rallies 2.3% in Hong Kong

Dow Jones
·
Aug 25

Sino Biopharmaceutical Stock Advances 5.8% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 22

Stock Track | SINO BIOPHARM Soars 5.96% on Breakthrough Drug Designation and Strong H1 Results

Stock Track
·
Aug 22

Hong Kong Stock Alert | SINO BIOPHARM (01177) Surges Over 6% Again as Zonartinib Receives CDE Breakthrough Therapy Designation, H1 Results Exceed Market Expectations

Stock News
·
Aug 22

Sino Biopharmaceutical's Lung Cancer Drug Gets Breakthrough Therapy Status

MT Newswires Live
·
Aug 21

SINO BIOPHARM (01177): Selective HER2 TKI "Zongaitinib" Receives CDE Breakthrough Therapy Designation Again

Stock News
·
Aug 20

BRIEF-Sino Biopharmaceutical Says Her2-Selective TKI Granted Breakthrough Therapeutic Designation

Reuters
·
Aug 20

Sino Biopharmaceutical Ltd - Her2-Selective Tki Granted Breakthrough Therapeutic Designation by Nmpa

THOMSON REUTERS
·
Aug 20

Sino Biopharm's Unit Gets Breakthrough Therapy Status for Gastric Cancer Drug in China

MT Newswires Live
·
Aug 20

BRIEF-Sino Biopharmaceutical LM-302 Included In Breakthrough Therapeutic Designation Process By China's NMPA

Reuters
·
Aug 19